Related Experiment Video
Updated: Apr 12, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.8K
Cognitive dysfunction and hepatitis C virus infection.
Antonio Solinas1, Maria Rita Piras1, Angelo Deplano1
1Antonio Solinas, Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
World Journal of Hepatology
|May 9, 2015
Summary
Chronic hepatitis C virus (HCV) infection causes cognitive dysfunction, similar to minimal hepatic encephalopathy (MHE). Further research is needed to understand HCV
Area of Science:
- Neuroscience and Hepatology
- Investigating the neurological impact of viral infections
Background:
- Chronic hepatitis C virus (HCV) infection is associated with cognitive dysfunction, presenting as a form of minimal hepatic encephalopathy (MHE).
- Most HCV-positive patients exhibit cognitive deficits in verbal learning, attention, executive function, and memory, regardless of liver fibrosis severity.
- The relationship between HCV-induced cognitive issues and metabolic alterations in advanced liver disease, and their reversibility with treatment, remains unclear.
Purpose of the Study:
- To clarify the similarities between HCV-related cognitive dysfunction and MHE from other causes.
- To investigate the interaction of metabolic alterations in advanced liver disease with HCV-induced cognitive dysfunction.
- To determine if antiviral therapies can reverse HCV-associated cognitive deficits.
Main Methods:
- Utilizing longitudinal studies with protocols aligned with the DSM-5 for cognitive disorders.
- Evaluating domains including complex attention, executive functions, learning and memory, perceptual motor functions, and social cognition.
- Integrating advanced neuroimaging techniques: FDG-PET, MRI (spectroscopy, DTI, perfusion, fMRI), and assessing portal hypertension characteristics.
Main Results:
- HCV replication in the brain may contribute to neuroinflammation and cognitive impairment.
- HCV-related brain dysfunction is potentially linked to white matter changes, altered association tracts, and reduced perfusion.
- The extent to which HCV causes irreversible neurodegenerative damage in cirrhotic patients requires further investigation.
Conclusions:
- HCV infection significantly impacts cognitive function, warranting further research into its pathogenesis and treatment.
- Advanced neuroimaging and standardized cognitive assessments are crucial for understanding HCV-related brain dysfunction.
- Longitudinal studies are essential to elucidate the long-term neurological consequences of HCV and the potential for recovery.
Related Concept Videos
01:25Hepatitis
59
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
59
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
353
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
353
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
263
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
352
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
352
01:30Negative and Cognitive Symptoms of Schizophrenia
1.1K
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
1.1K
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
324
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
324